Ambu A/S (OTCMKTS:AMBBY) Stock Price Up 13.4% – Here’s What Happened

Shares of Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) traded up 13.4% on Wednesday. The stock traded as high as $13.20 and last traded at $13.20. Approximately 101 shares were traded during mid-day trading, a decline of 85% from the average session volume of 655 shares. The stock had previously closed at $11.64.

Analysts Set New Price Targets

Separately, UBS Group lowered shares of Ambu A/S from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 15th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat, Ambu A/S has an average rating of “Hold”.

Ambu A/S Trading Up 9.1%

The business’s 50 day simple moving average is $11.01 and its 200 day simple moving average is $11.00. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.77 and a quick ratio of 1.69. The company has a market capitalization of $3.10 billion, a price-to-earnings ratio of 44.00 and a beta of 0.86.

Ambu A/S (OTCMKTS:AMBBY) last announced its earnings results on Tuesday, August 25th. The company reported $0.09 earnings per share for the quarter. Ambu A/S had a net margin of 8.18% and a return on equity of 8.49%. The business had revenue of $255.12 million during the quarter.

Ambu A/S Company Profile

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.